Bloomberg IntelligenceBloomberg Intelligence

Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

View descriptionShare

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Intelligence

Listen for investment news and in-depth company research. Hosts Paul Sweeney and Scarlet Fu harnes 
Social links
Follow podcast
Recent clips
Browse 3,350 clip(s)